Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
148,275,293
-
Number of holders
-
68
-
Total 13F shares, excl. options
-
16,716,696
-
Shares change
-
+641,350
-
Total reported value, excl. options
-
$407,455,000
-
Value change
-
+$14,912,147
-
Number of buys
-
48
-
Number of sells
-
-29
-
Price
-
$24.37
Significant Holders of 89bio, Inc. - Common stock, par value $0.001 per share (ETNB) as of Q4 2020
83 filings reported holding ETNB - 89bio, Inc. - Common stock, par value $0.001 per share as of Q4 2020.
89bio, Inc. - Common stock, par value $0.001 per share (ETNB) has 68 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 16,716,696 shares
of 148,275,293 outstanding shares and own 11% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (4,736,214 shares), ORBIMED ADVISORS LLC (3,729,442 shares), WELLINGTON MANAGEMENT GROUP LLP (1,264,911 shares), EVENTIDE ASSET MANAGEMENT, LLC (869,000 shares), FRANKLIN RESOURCES INC (686,039 shares), BlackRock Inc. (658,833 shares), CITADEL ADVISORS LLC (489,953 shares), FMR LLC (453,740 shares), MORGAN STANLEY (436,969 shares), and Acuta Capital Partners, LLC (434,400 shares).
This table shows the top 68 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.